← Home India · nd-india

Abbott announces new real─world evidence linking Cologuard screening to lower colorectal cancer incidence and odds of death

Source: pharmabiz · 2026-10-14T02:00:00 UTC

Abbott announced new real─world evidence showing that completion of multitarget stool DNA (mt─sDNA) screening was associated with approximately 54% lower colorectal cancer incidence and 45% lower odds

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Related in India